MedTrace Logo

Kinetic of Melatonin Subsequent to the Consumption of Melatonin-rich Food Supplements

NCT04574141 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-03-22

No results posted yet for this study

Summary

This study is conducted to clinically document the melatonin bioavailability of two dietary supplements containing melatonin : one prolonged release tablet dosed at 1.9mg and one spray dosed at 1mg for 2 oral sprays.

Conditions

  • Melatonin Bioavailability

Interventions

DIETARY_SUPPLEMENT

a prolonged release tablet and a spray containing melatonin

prolonged release tablet is dosed at 1.9mg and spray is dosed at 1mg for 2 oral sprays.

Sponsors & Collaborators

  • PiLeJe

    lead INDUSTRY

Principal Investigators

  • Bruno Claustrat · PiLeJe

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-13
Primary Completion
2020-10-05
Completion
2020-10-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574141 on ClinicalTrials.gov